Home / FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
Mertens L.S. 1,
Van Rhijn B.W.G. 1,
Mayr R. 2,
Bostrom P.J. 3,
Marquez M. 4,
Zwarthoff E.C. 5,
Boormans J.L. 6,
Abas C. 5,
Van Leenders G. 5,
Neuzillet Y. 1,
Van Der Heijden M.S. 7,
Real F.X. 4,
Stohr R. 8,
Zlotta A.R. 9,
Eckstein M. 8,
Soorojebally Y. 10,
Burger M. 2,
Radvanyi F. 10,
Sirab N. 10,
Pouessel D. 10,
Van Der Kwast T.H. 11,
Malats N. 4,
Hartmann A. 8,
Allory Y. 10,
Zuiverloon T. 6
1
Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Dept of Surgical Oncology, Urology, Amsterdam, The Netherlands 2
Caritas St Joseph Medical Center, University of Regensburg , Dept. of Urology, Regensburg, Germany 3
University of Turku, Dept. of Urology, Turku, Finland 4
CNIO, Dept. of Genetic Molecular Epidemiology and Cancer Biology, Madrid, Spain 5
Erasmus MC, Dept. of Pathology, Rotterdam, The Netherlands 6
Erasmus MC, Dept. of Urology, Rotterdam, The Netherlands 7
Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Dept. of Medical Oncology, Amsterdam, The Netherlands 8
University of Erlangen, Dept. of Pathology, Erlangen, Germany 9
University Health Network, Dept. of Urology, Toronto, Canada 10
Institut Curie, Dept. of Pathology, Paris, France 11
University Health Network, Dept. of Pathology, Toronto, Canada
